Hikal Limited is a global company that specializes in providing research-driven, custom manufacturing solutions to the pharmaceutical and specialty chemicals industries. The company has established itself as a reliable partner for leading companies worldwide, offering an extensive range of products and services.

Hikal's core business areas include active pharmaceutical ingredients (APIs), advanced intermediates, and exclusive synthesis solutions. Their diverse portfolio enables them to cater to various therapeutic categories such as oncology, central nervous system disorders, cardiovascular diseases, and more.

One of the key factors that set Hikal apart from its competitors is its relentless focus on innovation and sustainable practices. The company leverages cutting-edge technologies in process development and optimization to deliver high-quality products while minimizing environmental impact. In addition to their commitment to technological advancement, Hikal also distinguishes itself through strategic partnerships with leading global pharmaceutical companies. These collaborations enable the company to co-create innovative solutions tailored to specific market needs while expanding its reach across different regions. With state-of-the-art facilities located in India, Germany, USA, and Japan along with a dedicated team of scientists and engineers, Hikal has built a strong reputation for excellence in quality compliance and regulatory standards. This has positioned them as a preferred choice for businesses seeking reliable partners for their chemical manufacturing requirements.